Transection Aorta

2

Review clinical trials related to Transection Aorta. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical practice. This post-market registry for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CTAG w/AC) is intended to demonstrate that thoracic endovascular aortic repair (TEVAR) for lesions of the descending thoracic aorta continues to be a suitable treatment option for appropriately selected patients.

Participants needed: 1,500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: W.L.Gore & AssociatesUpdated: Jun 23, 2026Locations: 36Duration: 10 Years
Eligibility criteria

Patient or legally authorized representative (LAR) provides written authorizatio... [+3]

Patient who is, at the time of consent, unlikely to be available for standard of... [+3]

Status: Recruiting

Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis

The goal of this observational study is to collect mid-term post-market clinical follow-up data of GORE® TAG® Thoracic Branch Endoprosthesis used according to the standard medical practice in patients presenting with vascular disease. This registry aims to answer questions related to the efficacy and safety of GORE® TAG® Thoracic Branch Endoprosthesis.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: W.L.Gore & AssociatesUpdated: May 9, 2025Locations: 20Duration: 2 Years
Eligibility criteria

Not listed